Schnieders Capital Management LLC Purchases 268 Shares of Intuitive Surgical, Inc. $ISRG

Schnieders Capital Management LLC lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 38.0% during the 2nd quarter, Holdings Channel reports. The firm owned 973 shares of the medical equipment provider’s stock after purchasing an additional 268 shares during the quarter. Schnieders Capital Management LLC’s holdings in Intuitive Surgical were worth $529,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also bought and sold shares of the company. Chilton Capital Management LLC lifted its position in shares of Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 43 shares during the last quarter. Elite Financial Inc. acquired a new stake in Intuitive Surgical during the 1st quarter valued at $26,000. LFA Lugano Financial Advisors SA bought a new position in Intuitive Surgical during the first quarter worth $30,000. TD Capital Management LLC increased its holdings in shares of Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 45 shares during the last quarter. Finally, 1248 Management LLC bought a new position in shares of Intuitive Surgical in the first quarter valued at about $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 335 shares of the company’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total transaction of $147,631.15. Following the completion of the sale, the director directly owned 739 shares in the company, valued at $325,669.91. This represents a 31.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Myriam Curet sold 4,500 shares of the firm’s stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. This represents a 92.73% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 45,224 shares of company stock valued at $21,716,492. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $446.13 on Monday. The company has a market cap of $159.93 billion, a price-to-earnings ratio of 62.22, a PEG ratio of 4.69 and a beta of 1.61. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The stock has a fifty day moving average price of $454.97 and a 200-day moving average price of $495.76.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The business had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter in the previous year, the firm earned $1.78 earnings per share. Intuitive Surgical’s revenue for the quarter was up 21.4% compared to the same quarter last year. Research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. Truist Financial cut their price objective on shares of Intuitive Surgical from $600.00 to $525.00 and set a “buy” rating for the company in a research report on Wednesday, October 15th. Weiss Ratings reissued a “hold (c+)” rating on shares of Intuitive Surgical in a report on Wednesday, October 8th. Mizuho decreased their price objective on Intuitive Surgical from $570.00 to $520.00 and set a “neutral” rating on the stock in a report on Tuesday, October 14th. Robert W. Baird dropped their target price on Intuitive Surgical from $600.00 to $536.00 and set an “outperform” rating for the company in a report on Wednesday, October 15th. Finally, Wall Street Zen cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday. Fourteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $580.29.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.